4-phenyl-N-(pyridin-4-yl)tetrahydro-2H-pyran-4-carboxamide

ID: ALA490941

PubChem CID: 755212

Max Phase: Preclinical

Molecular Formula: C17H18N2O2

Molecular Weight: 282.34

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  O=C(Nc1ccncc1)C1(c2ccccc2)CCOCC1

Standard InChI:  InChI=1S/C17H18N2O2/c20-16(19-15-6-10-18-11-7-15)17(8-12-21-13-9-17)14-4-2-1-3-5-14/h1-7,10-11H,8-9,12-13H2,(H,18,19,20)

Standard InChI Key:  AQTYBNUVNMQOJK-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 21 23  0  0  0  0  0  0  0  0999 V2000
   16.2600  -15.8155    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.9701  -15.3987    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.9641  -14.5797    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.2496  -14.1715    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   15.5395  -14.5884    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.5438  -15.4135    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.6939  -16.2462    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.6926  -17.0734    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   13.4054  -17.4862    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.1244  -17.0730    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.1213  -16.2422    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.4034  -15.8336    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.8334  -15.8263    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   15.5496  -16.2351    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.5537  -17.0598    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   16.9780  -16.2281    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.9805  -17.0536    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.6959  -17.4624    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.4090  -17.0465    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.4023  -16.2175    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.6862  -15.8126    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
 10 11  1  0
  4  5  1  0
 11 12  2  0
 12  7  1  0
  5  6  1  0
 11 13  1  0
 13 14  1  0
  1  2  1  0
 14 15  2  0
 14  1  1  0
  7  8  2  0
  1 16  1  0
  1  6  1  0
 16 17  2  0
  8  9  1  0
 17 18  1  0
  2  3  1  0
 18 19  2  0
  9 10  2  0
 19 20  1  0
  3  4  1  0
 20 21  2  0
 21 16  1  0
M  END

Alternative Forms

Associated Targets(non-human)

cyp51 Lanosterol 14-alpha demethylase (36 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 282.34Molecular Weight (Monoisotopic): 282.1368AlogP: 2.77#Rotatable Bonds: 3
Polar Surface Area: 51.22Molecular Species: NEUTRALHBA: 3HBD: 1
#RO5 Violations: HBA (Lipinski): 4HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: 13.11CX Basic pKa: 5.64CX LogP: 2.10CX LogD: 2.10
Aromatic Rings: 2Heavy Atoms: 21QED Weighted: 0.94Np Likeness Score: -1.31

References

1. Podust LM, von Kries JP, Eddine AN, Kim Y, Yermalitskaya LV, Kuehne R, Ouellet H, Warrier T, Alteköster M, Lee JS, Rademann J, Oschkinat H, Kaufmann SH, Waterman MR..  (2007)  Small-molecule scaffolds for CYP51 inhibitors identified by high-throughput screening and defined by X-ray crystallography.,  51  (11): [PMID:17846131] [10.1128/aac.00311-07]

Source